Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clock Proteins as a Prognostic Marker for Disease Progression

NCT06302959 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT06302959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clock Proteins as a Prognostic Marker for Disease Progression
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Terminated
Start date
May 1, 2024
Completion date
September 9, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe eosinophilic asthma